Noubar B. Afeyan
Director at Moderna. Based in Cambridge, Massachusetts.
- Rank
- 520th of 14,452
- Companies held
- 1
- Largest holding
- MRNA, 100.0% of total
- Latest SEC filing
- May 21, 2026
- Listed but not counted
- $923M
What the $444M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Moderna MRNA Common Stock | Directly | 2,224,015 | $199.33 | $443M | 99.8% | Form 4, May 21, 2026 |
| Moderna MRNA Common Stock | Through Flagship Pioneering, LLC | 3,924 | $199.33 | $782K | 0.2% | Form 4, May 21, 2026 |
Share counts are the amounts Noubar B. Afeyan reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Noubar B. Afeyan's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Moderna MRNA Common Stock | Through Flagship Ventures Fund IV, L.P. Held by a company or fund the insider manages | 3,880,328 | $199.33 | $773M | — | Form 4, May 21, 2026 |
| Moderna MRNA Common Stock | Through Flagship Ventures Fund IV-Rx, L.P. Held by a company or fund the insider manages | 747,897 | $199.33 | $149M | — | Form 4, May 21, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 517 | Yoshiyuki Aikawa Chairman and CEO, SBC Medical Group Holdings. Irvine, CA | $446M |
| 518 | Raul Marcelo Claure Director, T-Mobile US. Bellevue, WA | $445M |
| 519 | Keith Manchester Director, Roivant Sciences | $445M |
| 520 | Noubar B. Afeyan Director, Moderna. Cambridge, MA | $444M |
| 521 | Lawrence James Lawson III Director, Lincoln International. Chicago, IL | $443M |
| 522 | Philip H. Knight Insider, NIKE. Beaverton, OR | $441M |
| 523 | Yair Nechmad CEO, Co Founder & Chairman, Nayax | $438M |
Other Moderna insiders
All MRNA insiders- Robert Langer$2.29BDirector. #136 overall
- Stephane Bancel$1.28BChief Executive Officer. #211 overall
- Stephen Hoge$292MPresident. #692 overall
- Paul Sagan$98.5MDirector. #1520 overall
- Juan Andres$24.9MChief Operating Officer. #4257 overall
- Shannon Thyme Klinger$16.2MChief Legal Officer. #6048 overall
Questions
How much stock does Noubar B. Afeyan own?
Noubar B. Afeyan holds $444,095,081 in listed stock based on SEC filings and current prices, mostly Moderna (MRNA). That ranks 520th on the Stock Rich List.
Is this Noubar B. Afeyan's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Noubar B. Afeyan last buy or sell stock?
The most recent open-market trade on file is a sale of 9,263 MRNA shares on May 21, 2026 at $46.84.